ஆராய்ச்சி வரி கடன் பிரஞ்சு Cr News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from ஆராய்ச்சி வரி கடன் பிரஞ்சு cr. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In ஆராய்ச்சி வரி கடன் பிரஞ்சு Cr Today - Breaking & Trending Today

DBV Technologies S.A.: DBV Technologies Reports Second Quarter 2021 Financial Results and Recent Business Developments

DBV Technologies S.A.: DBV Technologies Reports Second Quarter 2021 Financial Results and Recent Business Developments
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

France General , United States , New Jersey , United Kingdom , Daniel Tasse , Anne Pollak , Angela Marcucci , International Financial Reporting Standards , Company Adss , Health Science , Drug Administration , Us District Court , Exchange Commission , Research Tax Credit French Cr , European Union , European Medicines Agency , Reports Second Quarter , Resultsand Recent Business , Viaskin Peanut , Action Complaint , Second Amended Class Action Complaint , Budget Measures , Stock Market , Chief Executive Officer , Hesion Among Modified Patches , Modified Patches ,

DBV Technologies Reports Q1 2021 Financial Results

DBV Technologies Reports Q1 2021 Financial Results
May 03, 2021 01:30 ET
| Source:
DBV Technologies S.A.
DBV Technologies S.A.
DBV Technologies
Financial Results
DBV Technologies S.A. (Euronext: DBV – ISIN: FR0010417345 – Nasdaq Stock Market: DBVT), a clinical-stage biopharmaceutical company, today reported financial results for the first quarter of 2021. The quarterly financial statements were approved by the Board of Directors on April 30, 2021.
“
through the first quarter of 2021,” said Daniel Tasse, Chief Executive Officer, DBV Technologies. “
We remain diligent about our spend and confident that
our cash on hand as of March 31, 2021 will support our operations
until the second half of 2022. We continue to focus our attention on advancing ....

France General , Daniel Tasse , Research Tax Credit French Cr , Health Science , Nasdaq Stock Market , Chief Executive Officer , Viaskin Peanut , Cash Equivalents , Tax Credit , பிரான்ஸ் ஜநரல் , டேனியல் டாஸ் , ஆராய்ச்சி வரி கடன் பிரஞ்சு Cr , ஆரோக்கியம் அறிவியல் , நாஸ்டாக் ஸ்டாக் சந்தை , தலைமை நிர்வாகி அதிகாரி , வரி கடன் ,

DBV Technologies S.A.: DBV Technologies Reports Full-Year 2020 Financial Results and Recent Business Developments

DBV Technologies S.A.: DBV Technologies Reports Full-Year 2020 Financial Results and Recent Business Developments
DBV Technologies Reports Full-Year 2020 Financial Results and Recent Business Developments
DBV Technologies S.A. (Euronext: DBV - ISIN: FR0010417345 - Nasdaq Stock Market: DBVT), a clinical-stage biopharmaceutical company, today reported financial results for the year ended December 31, 2020. The financials have been audited by the Company s statutory auditors and were approved by the Board of Directors on March 11, 2021. The audit report will be issued by the Company s auditors in March 2021.

DBV ended 2020 well positioned to advance Viaskin Peanut towards potential approval in both the United States and European Union, said Daniel Tasse, Chief Executive Officer of DBV Technologies. ....

France General , New York , United States , United Kingdom , Daniel Tasse , Anne Pollak , Angela Marcucci , International Financial Reporting Standards , Company Adss , Health Science , Exchange Commission , Research Tax Credit French Cr , European Union , European Medicines Agency , Reports Full Year , Recent Business Developments , Stock Market , Viaskin Peanut , Chief Executive Officer , Cash Equivalents , Tax Credit , North American , Euronext Paris , Nasdaq Global Select Market , French Autorit , Des March ,